# Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/use-of-eculizumab-for-atypical-haemolytic-uraemic-syndrome-and-c3/

## Facts

| Field | Value |
| --- | --- |
| Author Names | on behalf of the French Study Group for aHUS/C3G,Julien Zuber,Fádi Fakhouri,Lubka T. Roumenina,Chantal Loirat,Véronique Frémeaux‐Bacchi |
| Citations | 496 |
| DOI | 10.1038/nrneph.2012.214 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2139585104 |
| PMID | 23026949 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Fádi Fakhouri](https://scholariq.org/researchers/fadi-fakhouri/)

## Paper journal

- [Nature Reviews Nephrology](https://scholariq.org/journals/nature-reviews-nephrology/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.